Li Peng, PhDChief Scientific Officer at Palleon PharmaceuticalsSpeaker
Agenda Sessions
Targeted Tumor Desialylation by a Sialidase-Armed Anti-B7-H3 Nanobody Enhances Antitumor Immunity on core
, 11:30amView Session
